CONMED Operating Income 2010-2024 | CNMD

CONMED operating income from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
CONMED Annual Operating Income
(Millions of US $)
2023 $121
2022 $70
2021 $110
2020 $46
2019 $79
2018 $71
2017 $47
2016 $38
2015 $51
2014 $53
2013 $57
2012 $65
2011 $8
2010 $57
2009 $28
CONMED Quarterly Operating Income
(Millions of US $)
2024-09-30 $66
2024-06-30 $47
2024-03-31 $35
2023-12-31 $50
2023-09-30 $30
2023-06-30 $27
2023-03-31 $13
2022-12-31 $-1
2022-09-30 $24
2022-06-30 $24
2022-03-31 $22
2021-12-31 $37
2021-09-30 $27
2021-06-30 $26
2021-03-31 $20
2020-12-31 $25
2020-09-30 $29
2020-06-30 $-21
2020-03-31 $13
2019-12-31 $28
2019-09-30 $21
2019-06-30 $19
2019-03-31 $12
2018-12-31 $26
2018-09-30 $12
2018-06-30 $17
2018-03-31 $17
2017-12-31 $23
2017-09-30 $13
2017-06-30 $13
2017-03-31 $-2
2016-12-31 $13
2016-09-30 $14
2016-06-30 $8
2016-03-31 $4
2015-12-31 $13
2015-09-30 $15
2015-06-30 $12
2015-03-31 $11
2014-12-31 $17
2014-09-30 $2
2014-06-30 $16
2014-03-31 $17
2013-12-31 $16
2013-09-30 $9
2013-06-30 $16
2013-03-31 $16
2012-12-31 $17
2012-09-30 $14
2012-06-30 $17
2012-03-31 $17
2011-12-31 $-42
2011-09-30 $16
2011-06-30 $17
2011-03-31 $17
2010-12-31 $14
2010-09-30 $15
2010-06-30 $15
2010-03-31 $14
2009-12-31 $11
2009-09-30 $5
2009-06-30 $5
2009-03-31 $7
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.162B $1.245B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $73.526B 20.06
Becton Dickinson (BDX) United States $64.714B 17.01
Cardinal Health (CAH) United States $28.315B 15.35
West Pharmaceutical Services (WST) United States $23.683B 48.37
Labcorp (LH) United States $18.984B 15.74
Cooper (COO) United States $18.348B 24.85
Align Technology (ALGN) United States $15.944B 30.51
Henry Schein (HSIC) United States $8.597B 16.38
Merit Medical Systems (MMSI) United States $5.611B 28.65
DENTSPLY SIRONA (XRAY) United States $3.671B 9.98
Patterson (PDCO) United States $2.730B 14.58
STAAR Surgical (STAA) United States $1.231B 45.42
Lifevantage (LFVN) United States $0.222B 29.55
Pro-Dex (PDEX) United States $0.151B 30.10